These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21807980)

  • 21. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced porin expression with EnvZ-OmpR, PhoPQ, BaeSR two-component system down-regulation in carbapenem resistance of Klebsiella Pneumoniae based on proteomic analysis.
    Zhang K; Liu L; Yang M; Chen C; Li X; Tian J; Luo C; Wang X; Wang M
    Microb Pathog; 2022 Sep; 170():105686. PubMed ID: 35917986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate.
    Ma P; Laibinis HH; Ernst CM; Hung DT
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
    Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
    J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Strahilevitz J; Motro Y; Temper V; Merezhko D; Ayalon O; Bar Moshe Y; Lam MMC; Holt KE; Moran-Gilad J
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0066324. PubMed ID: 38990012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.
    Sugawara E; Kojima S; Nikaido H
    J Bacteriol; 2016 Dec; 198(23):3200-3208. PubMed ID: 27645385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36.
    Shin SY; Bae IK; Kim J; Jeong SH; Yong D; Kim JM; Lee K
    J Med Microbiol; 2012 Feb; 61(Pt 2):239-245. PubMed ID: 21940650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
    Tian X; Wang Q; Perlaza-Jiménez L; Zheng X; Zhao Y; Dhanasekaran V; Fang R; Li J; Wang C; Liu H; Lithgow T; Cao J; Zhou T
    BMC Microbiol; 2020 Jul; 20(1):218. PubMed ID: 32689945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.
    Crowley B; Benedí VJ; Doménech-Sánchez A
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3679-82. PubMed ID: 12384391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
    Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH
    Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems.
    Tsai YK; Liou CH; Fung CP; Lin JC; Siu LK
    PLoS One; 2013; 8(11):e79640. PubMed ID: 24265784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.
    Correa L; Martino MD; Siqueira I; Pasternak J; Gales AC; Silva CV; Camargo TZ; Scherer PF; Marra AR
    BMC Infect Dis; 2013 Feb; 13():80. PubMed ID: 23398691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characteristics and genetic analysis of the genes related to carbapenemase, efflux pump, and outer membrane proteins in carbapenem-resistant Klebsiella pneumoniae.
    Onishi R; Shigemura K; Osawa K; Yang YM; Maeda K; Tanimoto H; Kado M; Fang SB; Fujisawa M
    Lett Appl Microbiol; 2023 Feb; 76(2):. PubMed ID: 36763780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
    García-Fernández A; Miriagou V; Papagiannitsis CC; Giordano A; Venditti M; Mancini C; Carattoli A
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4178-84. PubMed ID: 20660683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
    Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
    FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct carbapenems susceptibility profiles in isogenic isolates of Klebsiella pneumoniae presenting Ompk36 disruption and expression of down-regulated blaKPC-2.
    Souza PMS; Ribeiro ACOA; Pena EPN; Silva FAC; Calsa Júnior T; Morais MMC; Almeida ACS
    Braz J Biol; 2023; 83():e269946. PubMed ID: 37283335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    Cremanns M; Lange F; Gatermann SG; Pfennigwerth N
    J Antimicrob Chemother; 2022 May; 77(6):1578-1585. PubMed ID: 35265984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.